Allergan has announced the approval that its VUITY eye-drop presbyopia solution had just received the approval of the U.S. Foods & Drugs Administration (FDA). Phase 3 clinical studies have showed that VUITY, based on a formulation of pilocarpine and delivered by the company’s proprietary technology pHast, improved near and intermediate ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
To continue reading this article register now.